Cargando…

Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics

OBJECTIVE: To explore the autophagy-related prognostic signature (ARPs) via data mining in gene expression profiles for glioblastoma (GBM). METHODS: Using the Cancer Genome Atlas (TCGA) database, we obtained 156 GBM samples and 5 adjacent normal samples, and denoted them as discovery cohort. Univari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dongjiao, Jiang, Yuxue, Wang, Tie, Wang, Zhe, Zou, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097333/ https://www.ncbi.nlm.nih.gov/pubmed/35550147 http://dx.doi.org/10.1186/s12920-022-01261-5

Ejemplares similares

Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2020)

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses
por: Ye, Shengda, et al.
Publicado: (2022)

A Prognostic Autophagy-Related Gene Pair Signature and Small-Molecule Drugs for Hepatocellular Carcinoma
por: Song, ZeBing, et al.
Publicado: (2021)

Identification of key genes and small molecule drugs in osteoarthritis by integrated bioinformatics analysis
por: Liu, Zhendong, et al.
Publicado: (2023)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Identification of key candidate genes and small molecule drugs in cervical cancer by bioinformatics strategy
por: Tang, Xin, et al.
Publicado: (2018)

Identification of potential microRNAs in glioblastoma using bioinformatic analysis and prognostic evaluation
por: Sun, Zhenwei, et al.
Publicado: (2020)

Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis
por: Huang, Zhehao, et al.
Publicado: (2022)

Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis
por: Chen, Juan, et al.
Publicado: (2019)

Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma
por: Wang, Qiang-Wei, et al.
Publicado: (2020)

Identification of novel prognostic targets in glioblastoma using bioinformatics analysis
por: Yin, Xiaofeng, et al.
Publicado: (2022)

Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma
por: Li, Zhenhua, et al.
Publicado: (2020)

Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme
por: Qi, Fuwei, et al.
Publicado: (2020)

Genome-Wide Identification of Autophagy Prognostic Signature in Pancreatic Cancer
por: Yu, Jianfa, et al.
Publicado: (2021)

Identification of novel biomarkers and candidate small molecule drugs in rheumatoid arthritis and osteoarthritis based on bioinformatics analysis of high‐throughput data
por: Zuo, Bin, et al.
Publicado: (2020)

Identification of novel candidate genes and small molecule drugs in ovarian cancer by bioinformatics strategy
por: Wei, Min, et al.
Publicado: (2022)

Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer
por: Du, Xin-jie, et al.
Publicado: (2023)

Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma
por: Bi, Ying, et al.
Publicado: (2022)

A risk signature with four autophagy‐related genes for predicting survival of glioblastoma multiforme
por: Wang, Yulin, et al.
Publicado: (2020)

Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

Identification of Potential Biomarkers and Small Molecule Drugs for Cutaneous Melanoma Using Integrated Bioinformatic Analysis
por: Liu, Yong, et al.
Publicado: (2022)

Identification of three miRNAs signature as a prognostic biomarker in breast cancer using bioinformatics analysis
por: Sang, Meijie, et al.
Publicado: (2020)

Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value
por: Zhou, Yangmei, et al.
Publicado: (2019)

Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis
por: He, Zheng, et al.
Publicado: (2020)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Identification of hub genes and small-molecule compounds in medulloblastoma by integrated bioinformatic analyses
por: Liu, Zhendong, et al.
Publicado: (2020)

Identification of biomarkers and ceRNA network in glioblastoma through bioinformatic analysis and evaluation of potential prognostic values
por: Hong, Fan, et al.
Publicado: (2021)

Identification of hub genes and small molecule therapeutic drugs related to breast cancer with comprehensive bioinformatics analysis
por: Hao, Mingqian, et al.
Publicado: (2020)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
por: Xing, Jiahua, et al.
Publicado: (2022)

Identification of autophagy-associated genes and prognostic implications in adults with acute myeloid leukemia by integrated bioinformatics analysis
por: Zhang, Jing, et al.
Publicado: (2023)

Identification of monotonically expressed long non-coding RNA signatures for breast cancer using variational autoencoders
por: Wang, Dongjiao, et al.
Publicado: (2023)

Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses
por: Shu, Jun, et al.
Publicado: (2022)

An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach
por: Wang, Ziwei, et al.
Publicado: (2020)

Advanced Bioinformatics Analysis and Genetic Technologies for Targeting Autophagy in Glioblastoma Multiforme
por: Manea, Amanda J., et al.
Publicado: (2023)

Identification and Validation of Three Autophagy-Related Long Noncoding RNAs as Prognostic Signature in Cholangiocarcinoma
por: Liu, Ya Jun, et al.
Publicado: (2021)

Identification of Potential Biomarkers of Platelet RNA in Glioblastoma by Bioinformatics Analysis
por: Chen, Xianjun, et al.
Publicado: (2022)

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)
por: Xing, Qianwei, et al.
Publicado: (2020)

Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis
por: Kong, Yang, et al.
Publicado: (2022)

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma
por: Zhang, Ao, et al.
Publicado: (2023)

Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis
por: Zhang, Chunyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e9v6pn243gkjs7fonduvvqu6gg